|
| Acusphere Submits New Drug Application for FDA Approval of Imagify(TM) |
2 May 08, 09:07 |
|
| 28/04/2008 21:43:00 Business Wire Acusphere Inc. (NASDAQ: ACUS) announced today the submission of a New Drug Application (NDA) to the U.S. Food & Drug Administration (FDA) for approval to market its lead product candidate, Imagify(TM) (Perflubutane Polymer Microspheres for Injectable Suspension). |
| more |
|
